Viewing nowCombinationDapormet Extended Release Tablet 10/500 mg
Dapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 202108083 · Approved 2021.12.23
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps control blood sugar levels in patients with type 2 diabetes through the combination of dapagliflozin and metformin. It is especially effective when used in conjunction with dietary and exercise regimens to improve blood glucose levels. It can also be used in patients with cardiovascular disease or risk factors whose blood sugar is not adequately controlled, but expert guidance should be followed in such cases. This medication is used to improve blood sugar control and support cardiovascular health management in patients with type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended dose of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior experience of antidiabetic drug therapy for whom adequate glycemic control is difficult to achieve with monotherapy: When used as initial therapy in patients with no prior experience of antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be titrated gradually to reduce gastrointestinal adverse effects of metformin. In patients switching from combination therapy with dapagliflozin and metformin to this medicine, the dose of this medicine may be started at the doses of dapagliflozin and metformin previously taken. When converting from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Since any change may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. In some cases, the inactive ingredients of this medicine may be excreted in the feces as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, administration of this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Since metformin is excreted through the kidneys and renal function is more likely to decline in elderly patients, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).
This medication helps in controlling blood sugar. However, it can very rarely cause a severe condition known as lactic acidosis, so caution is advised. There is a risk of hypoglycemia when used with insulin or other diabetes medications, thus caution should be exercised. This medication should not be used in certain patients, such as those with an allergy to it, severely impaired renal function, dehydration, serious infections, type 1 diabetes, and pregnant or breastfeeding women. Additionally, patients scheduled for surgery or tests involving radiographic contrast agents should temporarily discontinue this medication. Careful use is required in patients with impaired renal function, elderly patients, or those with low fluid volume, and blood pressure and renal function should be regularly monitored. While taking this medication, genital infections or urinary tract infections may occur, so cleanliness should be maintained. Furthermore, hypoglycemic symptoms may occur, thus requiring dosage adjustments when taken with insulin or sulfonylurea medications. This medication may decrease vitamin B12 levels, so regular testing is necessary for long-term users. Excessive alcohol consumption should be avoided as it can increase the risk of lactic acidosis. If sudden fatigue, muscle pain, difficulty breathing, or abdominal pain occurs while taking this medication, consult a doctor immediately. This medication's safety and efficacy have not been established in children, and it should not be used in pregnant or breastfeeding women. In case of overdose, seek immediate medical attention for proper treatment, and store this medication out of reach of children in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is also safe to store at room temperature, between 1 and 30 degrees Celsius, avoiding extreme heat or cold.
Pink, biconvex, oval-shaped film-coated tablet
30 tablets/box [6 tablets (Alu-Alu) x 5], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.